Loading clinical trials...

Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT01676597

Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome

* The study will be a prospective open labelled double blinded randomized controlled study. * The study will be conducted on patients admitted to Department of Hepatology from 2012 to 2014 at Institut...

Lead sponsor: Institute of Liver and Biliary Sciences, India•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Dr Naveen Kumar, MD

CONTACT

011-46300000 naveenilbsdelhi@gmail.com

Dr Ankit Bhardwaj

CONTACT

011-46300000 bhardwaj.ankit3@gmail.com

Related studies

TERMINATEDPhase 2

Letrozole in Patients With Hepatopulmonary Syndrome

NCT04577001 · Hepatopulmonary Syndrome

UNKNOWNNA

Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia

NCT04004104 · Hepatopulmonary Syndrome

TERMINATEDPhase 2

Sorafenib for Hepatopulmonary Syndrome

NCT02021929 · Hepatopulmonary Syndrome

UNKNOWN

Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study

NCT03092401 · Hepatopulmonary Syndrome, Liver Cirrhosis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 17, 2013Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment80

Start dateSep 2012

Last updatedDec 17, 2013

Condition

Hepatopulmonary Syndrome

Locations shown

Institute of Liver and Biliary Sciences

New Delhi, National Capital Territory of Delhi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 17, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions